![Fredrick Hausheer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fredrick Hausheer
Plus aucun poste en cours
Historique de carrière de Fredrick Hausheer
Anciens postes connus de Fredrick Hausheer
Sociétés | Poste | Début | Fin |
---|---|---|---|
LEPU BIOPHARMA CO., LTD. | Directeur Technique/Scientifique/R&D | 10/12/2020 | 31/03/2022 |
Wuxi Apptec, Inc.
![]() Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Directeur Technique/Scientifique/R&D | 01/04/2019 | 01/10/2020 |
Shanghai Stock Exchange
![]() Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | Sales & Marketing | 01/04/2019 | 01/10/2020 |
BioNumerik Pharmaceuticals, Inc.
![]() BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Directeur Général | 01/06/1992 | 01/06/2015 |
Président | 01/06/1992 | 01/06/2015 | |
Fondateur | 01/06/1992 | 01/06/2015 |
Formation de Fredrick Hausheer
Graceland University | Undergraduate Degree |
University of Illinois At Urbana–Champaign | Graduate Degree |
University of Missouri | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Chine | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Sales & Marketing | 1 |
Chief Executive Officer | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 3 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
LEPU BIOPHARMA CO., LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Wuxi Apptec, Inc.
![]() Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Technology Services |
Shanghai Stock Exchange
![]() Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | Finance |
BioNumerik Pharmaceuticals, Inc.
![]() BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |
- Bourse
- Insiders
- Fredrick Hausheer
- Expérience